Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Phil Ness - Page 35

Author: Phil Ness

$838 Million neurosciences center broke ground in Connecticut
Biotechnology | COVID-19 | Diagnostics | Neurology | Therapeutics

$838 Million neurosciences center broke ground in Connecticut

On Aug. 31, 2022, the Yale New Haven Hospital broke ground on the $838 million, 505,000 square foot…

Read More $838 Million neurosciences center broke ground in ConnecticutContinue

AlphaFold revealed the structure of the protein universe
Medicine | Therapeutics

AlphaFold revealed the structure of the protein universe

On Jul. 28, 2022, AlphaFold, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI), announced they we’re releasing predicted…

Read More AlphaFold revealed the structure of the protein universeContinue

COVID-19 Vacations Redux
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine

COVID-19 Vacations Redux

COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer…

Read More COVID-19 Vacations ReduxContinue

Anixa Biosciences Announced Publication of Peer-Reviewed Journal Article Highlighting Ovarian Cancer Vaccine Technology
Biotechnology | Diagnostics | Disease | Oncology | Vaccine | Women's Health

Anixa Biosciences Announced Publication of Peer-Reviewed Journal Article Highlighting Ovarian Cancer Vaccine Technology

On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…

Read More Anixa Biosciences Announced Publication of Peer-Reviewed Journal Article Highlighting Ovarian Cancer Vaccine TechnologyContinue

Origins of the Black Death identified
Disease | Life Science History | Plague

Origins of the Black Death identified

On Jun, 15, 2022, a multidisciplinary team of scientists, announced they had obtained and studied ancient Y. pestis…

Read More Origins of the Black Death identifiedContinue

Wake Forest CCSG cut from 5 years to 3 as center changes leadership, administrative structure
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics

Wake Forest CCSG cut from 5 years to 3 as center changes leadership, administrative structure

May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…

Read More Wake Forest CCSG cut from 5 years to 3 as center changes leadership, administrative structureContinue

Multi-country outbreak reported in Twelve member nations not endemic for Mpox Virus
Biotechnology | Diagnostics | Infectious Disease | Therapeutics | Vaccine | WHO

Multi-country outbreak reported in Twelve member nations not endemic for Mpox Virus

On May 21, 2022, the World Health Organization (WHO) reported that since May 13, 2022, cases of mpox…

Read More Multi-country outbreak reported in Twelve member nations not endemic for Mpox VirusContinue

Evolution of DNA
Cartoons - Original | Life Science History | Prehistory

Evolution of DNA

he Evolution of DNA is an Illustration with the very small, requiring magnification, to the very large. Cast…

Read More Evolution of DNAContinue

Stanford University launched $75 million brain disease initiative
Biotechnology | Diagnostics | Disease | Neurology | Non-Profit Research | Therapeutics

Stanford University launched $75 million brain disease initiative

On Apr. 22, 2022, Stanford University announced it was awarded a $75 million gift from Nike co-founder Phil…

Read More Stanford University launched $75 million brain disease initiativeContinue

Fred Hutch and Seattle Cancer Care Alliance unite, reshaped relationship with UW Medicine
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Radiology | Therapeutics | Women's Health

Fred Hutch and Seattle Cancer Care Alliance unite, reshaped relationship with UW Medicine

On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…

Read More Fred Hutch and Seattle Cancer Care Alliance unite, reshaped relationship with UW MedicineContinue

The Priestley Medal was awarded to Peter B. Dervan
Biotechnology | Chemical

The Priestley Medal was awarded to Peter B. Dervan

On Mar. 20, 2022, the American Chemical Society awarded The Priestley Medal to Peter B. Dervan “to recognize…

Read More The Priestley Medal was awarded to Peter B. DervanContinue

Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola
Agriculture | Biotechnology | CRISPR | Genomics | USDA

Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola

On Mar. 1, 2022, Yield10 Bioscience announced that 2021 field test results showed that the trait C3020 tested…

Read More Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and CanolaContinue

The University of Virginia Cancer Center Received NCI Comprehensive Designation
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics

The University of Virginia Cancer Center Received NCI Comprehensive Designation

On Feb. 1, 2022, University of Virginia Cancer Center announced it had been awarded a Comprehensive Cancer Center…

Read More The University of Virginia Cancer Center Received NCI Comprehensive DesignationContinue

Biology of Valentines
Biology | Cartoons - Original | Neurology

Biology of Valentines

The Biology of Valentines illustrates the biological components of love combined with realities of life. Published Feb. 14,…

Read More Biology of ValentinesContinue

H5N1 highly pathogenic avian influenza (HPAI) Reported in indiana
Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Veterinary

H5N1 highly pathogenic avian influenza (HPAI) Reported in indiana

On Feb. 9, 2022, the Indiana Department of Health confirmed that a case of H5N1 highly pathogenic avian…

Read More H5N1 highly pathogenic avian influenza (HPAI) Reported in indianaContinue

Evolution of CRISPR
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Life Science History | Therapeutics

Evolution of CRISPR

The Evolution of CRISPR illustrates its climb out of the primordial ocean on the backs of eukaryotic cells…

Read More Evolution of CRISPRContinue

INOVIO Announced Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 Variants
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

INOVIO Announced Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 Variants

On Nov. 30, 2021, Inovio Pharma announced the company was rapidly moving to evaluate its COVID-19 DNA vaccine…

Read More INOVIO Announced Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 VariantsContinue

Calgary reinstates fluoridation in City’s water System
Chemical | Dentistry | Disease | Therapeutics

Calgary reinstates fluoridation in City’s water System

On Nov. 14, 2021, the Calgary city council voted to reinstate fluoridation in Calgary’s waters. The count was…

Read More Calgary reinstates fluoridation in City’s water SystemContinue

Life-Saving Vaccines
Biotechnology | Cartoons - Original | Infectious Disease | Life Science History | Measles | Polio | Vaccine

Life-Saving Vaccines

Our Life-Saving Vaccines cartoon illustrates four invaluable vaccines that have affected human civilization throughout history from smallpox and…

Read More Life-Saving VaccinesContinue

the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewal
Biotechnology | NIH | Oncology | Therapeutics

the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewal

On Oct. 4, 2021, the Fred & Pamela Buffett Cancer Center announced it had successfully renewed its National…

Read More the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewalContinue

FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19
COVID-19 | FDA | Therapeutics

FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19

On Jul. 29, 2021, Incyte announced the U.S. Food and Drug Administration (FDA) had broadened the Emergency Use…

Read More FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19Continue

FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
Biotechnology | FDA | Therapeutics

FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

On Jul. 29, 2021, BOTOX(R) Allergan, an AbbVie company, announced that the U.S. Food and Drug Administration (FDA)…

Read More FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb SpasticityContinue

Tufts Silklab Created Leather-like Material from Silk Proteins
Biotechnology | Materials

Tufts Silklab Created Leather-like Material from Silk Proteins

On May 5, 2021, researchers at Tufts University School of Engineering announced they had developed an alternative to…

Read More Tufts Silklab Created Leather-like Material from Silk ProteinsContinue

The Priestley Medal was awarded to Paul Alivisatos
Chemical | Energy | Materials | Nanotechnology

The Priestley Medal was awarded to Paul Alivisatos

On Apr. 9, 2021, the American Chemical Society awarded The Priestley Medal to Paul Alivisatos “to recognize distinguished…

Read More The Priestley Medal was awarded to Paul AlivisatosContinue

Merck Statement on Ivermectin use During the COVID-19 Pandemic
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Veterinary

Merck Statement on Ivermectin use During the COVID-19 Pandemic

On Feb. 4, 2021, Merck affirmed its position regarding use of ivermectin during the COVID-19 pandemic, and do…

Read More Merck Statement on Ivermectin use During the COVID-19 PandemicContinue

Zoetis Introducted Poulvac® Procerta™ HVT-IBD vaccine for infectious bursal disease
Biotechnology | Infectious Disease | USDA | Vaccine

Zoetis Introducted Poulvac® Procerta™ HVT-IBD vaccine for infectious bursal disease

On Jan. 21, 2021, Zoetis announced it had as expanded its line of recombinant vector vaccines with the…

Read More Zoetis Introducted Poulvac® Procerta™ HVT-IBD vaccine for infectious bursal diseaseContinue

FDA approved Saxenda for the treatment of obesity in adolescents aged 12-17
FDA | Medicine

FDA approved Saxenda for the treatment of obesity in adolescents aged 12-17

On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…

Read More FDA approved Saxenda for the treatment of obesity in adolescents aged 12-17Continue

NeuroRx and Relief announced successful results from expanded use of RLF-100 in patients with COVID-19
Biotechnology | COVID-19 | Disease | Therapeutics | Vaccine

NeuroRx and Relief announced successful results from expanded use of RLF-100 in patients with COVID-19

On Nov. 24, 2020, RELIEF THERAPEUTICS announced that more than 175 patients with Critical COVID-19 and Respiratory Failure…

Read More NeuroRx and Relief announced successful results from expanded use of RLF-100 in patients with COVID-19Continue

Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
Biotechnology | Pharmaceutical | Therapeutics

Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter

On Jul. 20, 2020, Sorrento announced that its partner Mabpharm had received approval of its New Drug Application…

Read More Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab BiobetterContinue

Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates

On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…

Read More Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidatesContinue

Page navigation

Previous PagePrevious 1 … 33 34 35 36 37 … 39 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search